Very rarely, the thyroid drug propylthiouracil has been linked to a condition where antibodies attack red blood cells in cold temperatures, causing anemia—without any infection being present.
Claim Context
Cold agglutinin disease is a rare but documented complication of propylthiouracil therapy, occurring in association with ANCA vasculitis and characterized by complement-mediated hemolysis without typical infectious triggers.
“While ANCA positivity is relatively common in patients treated with PTU, it does not predict the progression to systematic disease... While PTU intake is not typically linked with the development of cold agglutinin disease (CAD), rare instances have been reported previously.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
The pooled incidence of cold agglutinin disease among patients exposed to PTU compared to other antithyroid drugs, adjusting for exposure duration and age.
A systematic review and meta-analysis of all published case reports and cohort studies reporting CAD in patients treated with PTU or methimazole, with standardized diagnostic criteria for CAD and exclusion of secondary causes.
Whether PTU exposure increases the risk of developing cold agglutinin disease compared to methimazole in a large population over time.
A prospective cohort of 10,000 adults with Graves' disease treated with PTU or methimazole, monitored for 5 years with quarterly direct Coombs tests and clinical assessment for hemolytic anemia symptoms.
Whether prior PTU use is more common in patients diagnosed with drug-induced CAD than in matched controls without CAD.
A multicenter case-control study of 30 patients with confirmed drug-induced CAD and negative infectious serologies, matched to 90 controls without CAD, assessing prior exposure to PTU, methimazole, or other drugs.
That cold agglutinin disease can occur in a patient receiving PTU, with clinical and serologic features.
A detailed case report of a patient with Graves' disease on PTU who develops cold agglutinin disease confirmed by positive direct Coombs test for C3d and IgM, with cold agglutinin titer >1:64 at 4°C and no infectious cause.